Fennec Pharmaceuticals Ord Shs T.FRX

Alternate Symbol(s): FENC

Healthcare Biotechnology

Fennec Pharmaceuticals Inc. is a commercial-stage biopharmaceutical company focused on its product candidate PEDMARK. It sells its product through a field force, including Regional Pediatric Oncology Specialists and medical science liaisons who are helping to educate the medical communities and patients about cisplatin induced ototoxicity and its programs supporting patient access to PEDMARK. PEDMARK is a Food and Drug Administration approved therapy indicated to reduce the risk of ototoxicity associated with cisplatin treatment in pediatric patients with localized, non-metastatic, solid tumors. It is a formulation of sodium thiosulfate in single-dose, ready-to-use vials for intravenous use in pediatric patients. PEDMARK is a therapeutic agent with a dosing paradigm, across two open-label, randomized Phase 3 clinical studies, the Clinical Oncology Group (COG) Protocol ACCL0431 and SIOPEL 6. It has established Fennec HEARS, a single source program designed to connect PEDMARK patients.

TSX:FRX - Post by User

Fennec Pharmaceuticals Ord Shs

Bullboard Posts

Comment by dollarhunteron Aug 23, 2006 10:42am

254 Views

Post# 11261202

RE: Yahoo board

Thanks for the link to the yahoo board Brinkley. Investors do seem more positive over there but the very same stumbling block is uppermost in everybodies minds there too. Future financing!!! It has to be resolved quickly for the share price to return to it's previous levels. On another note, it looks like my purchases [ok call it averaging down] @ .34/.36 were close enough to the current bottom that the last few days action has left me feeling better. But hey I've been here for five years and will hold for the successful frenzy to come even if it's five years from now. Just my thoughts this am. Regards, DH

Bullboard Posts

DRI Healthcare stock drops 28% after executive changes